Matthias Cavassini
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
Gonvers J, Troilliet N, Negro F, Monnat M, Malinverni R, Dutoit V, Dufour F, Chuard C, Chave J, Cerny A, Borovicka J, Bernasconi E, Genné D, Mullhaupt B, Cavassini M, Heim M, Oneta C. Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study. Swiss Med Wkly 2010; 140:w13055.
Jul 19, 2010Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
Jul 19, 2010Swiss Med Wkly 2010; 140:w13055
Gonvers Jean-Jacques, Troilliet Nicolas, Negro Francesco, Monnat Martine, Malinverni Raffaelle, Dutoit Valérie, Dufour François, Chuard Christian, Chave Jean-Philippe, Cerny Andreas, Borovicka Jan, Bernasconi Enos, Genné Daniel, Mullhaupt Beat, Cavassini Matthias, Heim Markus H, Oneta Carl
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland
Kouyos R, Bonhoeffer S, Ledergerber B, Rickenbach M, Bernasconi E, Vernazza P, Battegay M, Furrer H, Cavassini M, Hirschel B, Weber R, Klimkait T, Bürgisser P, Shah C, Taffé P, Böni J, Yerly S, von Wyl V, Günthard H. Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. J Infect Dis 2010; 201:1488-97.
May 15, 2010Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland
May 15, 2010J Infect Dis 2010; 201:1488-97
Kouyos Roger D, Bonhoeffer Sebastian, Ledergerber Bruno, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Furrer Hansjakob, Cavassini Matthias, Hirschel Bernard, Weber Rainer, Klimkait Thomas, Bürgisser Philippe, Shah Cyril, Taffé Patrick, Böni Jürg, Yerly Sabine, von Wyl Viktor, Günthard Huldrych F
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir
Lubomirov R, Telenti A, Csajka C, Decosterd L, Buclin T, Descombes P, Rentsch K, Ledergerber B, Cavassini M, Calmy A, Vernazza P, Furrer H, Marzolini C, Martinez R, Colombo S, Fayet A, di Iulio J, Swiss HIV Cohort Study. ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir. Pharmacogenet Genomics 2010; 20:217-30.
Apr 1, 2010ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir
Apr 1, 2010Pharmacogenet Genomics 2010; 20:217-30
Lubomirov Rubin, Telenti Amalio, Csajka Chantal, Decosterd Laurent A, Buclin Thierry, Descombes Patrick, Rentsch Katharina, Ledergerber Bruno, Cavassini Matthias, Calmy Alexandra, Vernazza Pietro, Furrer Hansjakob, Marzolini Catia, Martinez Raquel, Colombo Sara, Fayet Aurélie, di Iulio Julia, Swiss HIV Cohort Study
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008
Elzi L, Battegay M, Weber R, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Ledergerber B, Furrer H, Marzolini C, Swiss HIV Cohort Study. Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. Archives of internal medicine 2010; 170:57-65.
Jan 11, 2010Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008
Jan 11, 2010Archives of internal medicine 2010; 170:57-65
Elzi Luigia, Battegay Manuel, Weber Rainer, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Cavassini Matthias, Ledergerber Bruno, Furrer Hansjakob, Marzolini Catia, Swiss HIV Cohort Study
Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy
Bucher H, Battegay M, Weber R, Vernazza P, Schiffer V, Fux C, Cavassini M, Bernasconi E, Vallet Y, Glass T, Young J, Rickenbach M, the Swiss HIV Cohort Study. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antivir Ther 2010; 15:31-40.
Jan 1, 2010Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy
Jan 1, 2010Antivir Ther 2010; 15:31-40
Bucher Heiner C, Battegay Manuel, Weber Rainer, Vernazza Pietro, Schiffer Véronique, Fux Christoph, Cavassini Matthias, Bernasconi Enos, Vallet Yannick, Glass Tracy R, Young Jim, Rickenbach Martin, the Swiss HIV Cohort Study
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
Marzolini C, Battegay M, Back D, Ledergerber B, Khoo S, Vernazza P, Calmy A, Bernasconi E, Cavassini M, Chave J, Furrer H, Fux C, Weber R, Gibbons S, Elzi L, Swiss HIV Cohort Study. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antivir Ther (Lond) 2010; 15:413-23.
Jan 1, 2010Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
Jan 1, 2010Antivir Ther (Lond) 2010; 15:413-23
Marzolini Catia, Battegay Manuel, Back David, Ledergerber Bruno, Khoo Saye, Vernazza Pietro, Calmy Alexandra, Bernasconi Enos, Cavassini Matthias, Chave Jean-Philippe, Furrer Hansjakob, Fux Christoph, Weber Rainer, Gibbons Sara, Elzi Luigia, Swiss HIV Cohort Study
Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study
Glass T, Bucher H, Günthard H, Rickenbach M, Bernasconi E, Hirschel B, Vernazza P, Furrer H, De Geest S, Cavassini M, Battegay M, the Swiss HIV Cohort Study. Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2009
Dec 23, 2009Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study
Dec 23, 2009Journal of acquired immune deficiency syndromes (1999) 2009
Glass Tracy R, Bucher Heiner C, Günthard Huldrych F, Rickenbach Martin, Bernasconi Enos, Hirschel Bernard, Vernazza Pietro, Furrer Hansjakob, De Geest Sabina, Cavassini Matthias, Battegay Manuel, the Swiss HIV Cohort Study
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study
Rotger M, Tarr P, Telenti A, Ledergerber B, Weber R, Witteck A, Furrer H, Hirschel B, Battegay M, Bernasconi E, Cavassini M, Martinez R, Taffé P, Bayard C, Swiss HIV Cohort Study. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study. Circulation. Cardiovascular genetics 2009; 2:621-8.
Dec 1, 2009Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study
Dec 1, 2009Circulation. Cardiovascular genetics 2009; 2:621-8
Rotger Margalida, Tarr Philip E, Telenti Amalio, Ledergerber Bruno, Weber Rainer, Witteck Andrea, Furrer Hansjakob, Hirschel Bernard, Battegay Manuel, Bernasconi Enos, Cavassini Matthias, Martinez Raquel, Taffé Patrick, Bayard Cornelia, Swiss HIV Cohort Study
High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland
Dang T, Tarr P, Odorico M, Cavassini M, Boffi El Amari E, Schmid P, Fehr J, Evison J, Kovari H, Flepp M, Jaton-Ogay K, Greub G. High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 49:1532-5.
Nov 15, 2009High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland
Nov 15, 2009Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 49:1532-5
Dang Thanh, Tarr Philip E, Odorico Massimo, Cavassini Matthias, Boffi El Amari Emmanuelle, Schmid Patrick, Fehr Jan, Evison John-Marc, Kovari Helen, Flepp Markus, Jaton-Ogay Katia, Greub Gilbert
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study
Khanna N, Hirsch H, Battegay M, Bernasconi E, Vernazza P, Fux C, Cavassini M, Garzoni C, Mueller N, Elzi L, Swiss HIV Cohort Study. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:1459-66.
May 15, 2009Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study
May 15, 2009Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:1459-66
Khanna Nina, Hirsch Hans H, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Fux Christoph A, Cavassini Matthias, Garzoni Christian, Mueller Nicolas J, Elzi Luigia, Swiss HIV Cohort Study
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland
von Wyl V, Günthard H, Ledergerber B, Bonhoeffer S, Francioli P, Vernazza P, Hirschel B, Furrer H, Cavassini M, Bernasconi E, Battegay M, Klimkait T, Bürgisser P, Yerly S, Swiss HIV Cohort Study. Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:979-87.
Apr 1, 2009Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland
Apr 1, 2009Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:979-87
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Bonhoeffer Sebastian, Francioli Patrick, Vernazza Pietro, Hirschel Bernard, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Bürgisser Philippe, Yerly Sabine, Swiss HIV Cohort Study
Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients
Veit O, Furrer H, Hatz C, Staub T, Litzba N, Bae H, Schmid P, Mossdorf E, Cavassini M, Chapuis-Taillard C, Niedrig M, Swiss HIV Cohort Study. Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:659-66.
Mar 1, 2009Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients
Mar 1, 2009Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:659-66
Veit Olivia, Furrer Hansjakob, Hatz Christoph, Staub Thomas, Litzba Nadine, Bae Hi-Gung, Schmid Patrick, Mossdorf Erik, Cavassini Matthias, Chapuis-Taillard Caroline, Niedrig Matthias, Swiss HIV Cohort Study
Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study
Conen A, Battegay M, Bucher H, Bernasconi E, Cavassini M, Hirschel B, Vernazza P, Weber R, Furrer H, Glass T, Fehr J, Swiss HIV Cohort Study. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antiviral therapy 2009; 14:349-57.
Jan 1, 2009Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study
Jan 1, 2009Antiviral therapy 2009; 14:349-57
Conen Anna, Battegay Manuel, Bucher Heiner C, Bernasconi Enos, Cavassini Matthias, Hirschel Bernard, Vernazza Pietro, Weber Rainer, Furrer Hansjakob, Glass Tracy R, Fehr Jan, Swiss HIV Cohort Study
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
Elzi L, Battegay M, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Fux C, Weber R, Kaufmann G, Swiss HIV Cohort Study. Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals. HIV clinical trials 2009; 10:207-14.
Jan 1, 2009Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
Jan 1, 2009HIV clinical trials 2009; 10:207-14
Elzi Luigia, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Cavassini Matthias, Fux Christoph A, Weber Rainer, Kaufmann Gilbert, Swiss HIV Cohort Study
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
Young J, Battegay M, Bernasconi E, Vernazza P, Cavassini M, Hirschel B, Fux C, Rickenbach M, Guenthard H, Bucher H, Swiss HIV Cohort Study. Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV. Antiviral therapy 2009; 14:771-9.
Jan 1, 2009Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
Jan 1, 2009Antiviral therapy 2009; 14:771-9
Young Jim, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Hirschel Bernard, Fux Christoph A, Rickenbach Martin, Guenthard Huldrych F, Bucher Heiner C, Swiss HIV Cohort Study
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007
Ballif M, Weber R, Opravil M, Rickenbach M, Furrer H, Hirschel B, Schmid P, Bernasconi E, Cavassini M, Battegay M, Ledergerber B, Swiss HIV Cohort Study. Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007. PloS one 2009; 4:e8275.
Jan 1, 2009Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007
Jan 1, 2009PloS one 2009; 4:e8275
Ballif Marie, Weber Rainer, Opravil Milos, Rickenbach Martin, Furrer Hansjakob, Hirschel Bernard, Schmid Patrick, Bernasconi Enos, Cavassini Matthias, Battegay Manuel, Ledergerber Bruno, Swiss HIV Cohort Study
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
Khanna N, Kaufmann G, Battegay M, Hirschel B, Weber R, Bernasconi E, Vernazza P, Cavassini M, Furrer H, Opravil M, Swiss HIV Cohort Study. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 47:1093-101.
Oct 15, 2008CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
Oct 15, 2008Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 47:1093-101
Khanna Nina, Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Weber Rainer, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Opravil Milos, Swiss HIV Cohort Study
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication
Ciuffreda D, Bernasconi E, Monnat M, Cerny A, Chuard C, Borovicka J, Mentha G, Pascual M, Gonvers J, Pantaleo G, Oneta C, Malinverni R, Comte D, Cavassini M, Giostra E, Buhler L, Perruchoud M, Heim M, Battegay M, Genné D, Mulhaupt B, Dutoit V. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. European journal of immunology 2008; 38:2665-77.
Oct 1, 2008Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication
Oct 1, 2008European journal of immunology 2008; 38:2665-77
Ciuffreda Donatella, Bernasconi Enos, Monnat Martine, Cerny Andreas, Chuard Christian, Borovicka Jan, Mentha Gilles, Pascual Manuel, Gonvers Jean-Jacques, Pantaleo Giuseppe, Oneta Carl, Malinverni Raffaele, Comte Denis, Cavassini Matthias, Giostra Emiliano, Buhler Leo, Perruchoud Monika, Heim Markus H, Battegay Manuel, Genné Daniel, Mulhaupt Beat, Dutoit Valérie
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study
Vo T, Weber R, Vernazza P, Bernasconi E, Cavassini M, Battegay M, Furrer H, Hirschel B, Keiser O, Ledergerber B, Swiss HIV Cohort Study. Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study. The Journal of infectious diseases 2008; 197:1685-94.
Jun 15, 2008Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study
Jun 15, 2008The Journal of infectious diseases 2008; 197:1685-94
Vo Thi Tuyet Nhung, Weber Rainer, Vernazza Pietro, Bernasconi Enos, Cavassini Matthias, Battegay Manuel, Furrer Hansjakob, Hirschel Bernard, Keiser Olivia, Ledergerber Bruno, Swiss HIV Cohort Study
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
El Amari E, Hirschel B, Bernasconi E, Hirsch H, Vernazza P, Cavassini M, Furrer H, Mueller N, Erb P, Steffen I, Cathomas G, Baumann M, Gayet-Ageron A, Toutous-Trellu L, Swiss HIV Cohort Study. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. AIDS (London, England) 2008; 22:1019-28.
May 31, 2008Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
May 31, 2008AIDS (London, England) 2008; 22:1019-28
El Amari Emmanuelle Boffi, Hirschel Bernard, Bernasconi Enos, Hirsch Hans H, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Mueller Nicolas J, Erb Peter, Steffen Ingrid, Cathomas Gieri, Baumann Michele, Gayet-Ageron Angèle, Toutous-Trellu Laurence, Swiss HIV Cohort Study